Get Healthy!

Semaglutide Helps Prevent Kidney Damage in People with Obesity

A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.

HealthDay
Health News is provided as a service to Hudson Pharmacy site users by HealthDay. Hudson Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.

Share


Tags